On July 21, 2026, the Johns Hopkins Bloomberg School of Public Health published findings from a major systematic review concluding that menopause care remains fragmented, unequal, and inadequate for women worldwide — leaving many without evidence-based support during a life stage that affects roughly half the global population. Reported the following day by FemTech World, the review drew on 89 studies (screened from 4,056 published records) spanning multiple countries and diverse populations, with most evidence coming from the UK, US, and Australia across qualitative, quantitative, mixed-methods, and intervention studies.

Why It Matters

This review is the clinical backdrop that explains — and validates — the entire menopause-tech gold rush. The femtech industry has raised record capital in 2026 (women's health pulled in a record $1.55B in disclosed equity in 2025), with a wave of menopause- and perimenopause-focused startups, wearables, and apps building precisely because the traditional care system is failing the market the review describes. Companies like Natural Cycles, Clue, Clair Health, Muun Health, Joylux, and Elysium — plus platform giants like Apple, which added perimenopause detection to Health in 2026 — are all racing to fill the "underserved and dismissed" gap this data quantifies. The review's endorsement of telehealth (with caveats) is a tailwind for digital menopause platforms, but its emphasis on equity is also a warning: the current wave of premium, English-language, high-income-market products risks widening the very disparities the researchers flag. For investors and founders, it's both a market-sizing signal and a mandate to design for the marginalized populations most poorly served today.

The picture it paints is bleak and familiar to anyone who has followed the menopause-tech boom. Women repeatedly reported feeling dismissed, unsupported, and uninformed about menopause and the treatments available to them. Services were fragmented, access to evidence-based treatment was limited, and support from healthcare providers was often inadequate. The review found that clinicians themselves frequently receive insufficient training on menopause, and that national clinical guidelines are applied inconsistently from provider to provider.

Crucially, the review documented persistent inequalities in who gets decent care. Race, socioeconomic status, cultural background, and geography all shaped the barriers women faced, with the gaps most severe among marginalized groups — LGBTQ+ people, Indigenous communities, migrant women, and those experiencing surgical menopause. Culturally responsive care, the authors noted, remains scarce.

The review did flag telehealth as a promising lever for widening access, but stopped short of calling it a cure-all — its acceptability and suitability varied across populations and settings. Instead, the authors called for better provider education and training, clearer roles across health services, patient-centered and culturally competent models of care, and a sharper focus on equity so high-quality menopause support reaches everyone, not just the well-resourced.

Sources

Update — 2026-07-23

Initial entry — story first created.